Related Experiment Video
Updated: Dec 24, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism
Aya Saiki1, Michio Otsuki1, Daisuke Tamada1
1Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Insights
Diabetes Mellitus (DM) increases cardiovascular and renal risks in Primary Aldosteronism (PA) patients. Managing DM is crucial for better outcomes in this population.
Area of Science:
- Endocrinology
- Nephrology
- Cardiology
Background:
- Primary aldosteronism (PA) patients have a higher prevalence of diabetes mellitus (DM) compared to essential hypertension and general populations.
- DM is a significant risk factor for cardio-cerebrovascular (CCV) diseases and renal complications, but its specific impact in PA remains unclear.
Purpose of the Study:
- To investigate the influence of coexistent DM on the risk of CCV events.
- To assess the effect of DM on the progression of renal complications in PA patients.
Main Methods:
- A multi-institutional, cross-sectional study enrolled 2524 PA patients from the Japan PA registry (2006-2016).
- Patients were categorized into DM and non-DM groups.
- Logistic and linear regression analyses compared CCV events and renal complications between the groups.
Main Results:
- DM significantly elevated the odds of CCV events (OR 1.59) and proteinuria (OR 2.25).
- DM showed a significant correlation with declining estimated glomerular filtration rate (β = .05, P = .02).
Conclusions:
- This study identifies DM as an independent risk factor for CCV events and renal complications in PA patients.
- Integrated management of DM alongside PA treatment is recommended for improved patient outcomes.
Context:
The prevalence of diabetes mellitus (DM) in patients with primary aldosteronism (PA) is higher than in those with essential hypertension and the general population. Although DM is a common major risk factor for cardio-cerebrovascular (CCV) diseases and renal complications, details of its effects in PA have not been demonstrated.
Objective:
The aim of this study was to determine the effects of coexistent DM on the risk of CCV events and progression of renal complications in PA patients.
Design:
A multi-institutional, cross-sectional study was conducted.
Patients And Methods:
PA patients experienced between January 2006 and October 2016 and with available data of CCV events and DM were enrolled from the Japan PA registry of the Japan Primary Aldosteronism Study/Japan Rare Intractable Adrenal Diseases Study (n = 2524). CCV events and renal complications were compared between a DM group and a non-DM group by logistic and liner-regression analysis.
Results:
DM significantly increased the odds ratio (OR) of CCV events (OR 1.59, 95% CI: 1.05-2.41) and that of proteinuria (OR 2.25, 95% CI: 1.59-3.16). DM correlated significantly with declines in estimated glomerular filtration rate (β = .05, P = .02).
Conclusions:
This the first report to demonstrate the presence of DM as an independent risk factor for CCV events and renal complications, even in PA patients. Management of DM should be considered in addition to the specific treatment of PA.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of β1 Blockers
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Diuretics

